Company: PFSA
Filing Date: 2025-06-13
Form Type: 10-Q
Source: 0001213900-25-054386
Chunk: 83

Company: Profusa, Inc.
Filing Date: 2025-06-13
Form: 10-Q
Item: Part I, Item 8
Chunk 83
---
NORTHVIEW ACQUISITION CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL
STATEMENTS

Note 1 – Description of Organization and Business Operations

NorthView Acquisition Corporation (the “Company”
or “Northview”) is a blank check company incorporated in Delaware on April 19, 2021. The Company was formed for the purpose
of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with
one or more businesses (“Business Combination”). The Company has identified a target company for a business combination and
is consummating the acquisition of Profusa.

The Company has a wholly-owned subsidiary, NV
Profusa Merger Sub Inc. (“Merger Sub”), a Delaware corporation incorporated on October 13, 2022, formed solely in contemplation
of the Merger with Profusa (See Note 6). Merger Sub has not commenced any operations and has only nominal assets and no liabilities or
contingent liabilities, nor any outstanding commitments other than in connection with the Merger.

On December 22, 2021, the Company consummated
its Initial Public Offering (“IPO”) of 18,975,000 units (the “Units”), which included 2,475,000 Units issued
pursuant to the full exercise of the over-allotment option granted to the underwriters. Each Unit consists of one share of common stock
of the Company, par value $0.0001 per share, one right (the “Rights”), and one-half of one redeemable warrant of the Company
(the “Warrants”). Each Right entitles the holder thereof to receive one-tenth (1/10) of one share of common stock. Each Warrant
entitles the holder thereof to purchase one share of common stock for $11.50 per share, subject to adjustment. The Units were sold at
a price of $10.00 per Unit, generating gross proceeds to the Company of $189,750,000.

Simultaneously with the closing of the IPO, the
Company completed the private sale of an aggregate of 7,347,500 warrants (the “Private Placement Warrants”), which included
697,500 Private Placement Warrants issued pursuant to the full exercise of the over-allotment option granted to the underwriters, to
NorthView Sponsor I, LLC (“the Sponsor”), I-Bankers Securities, Inc., and Dawson James Securities, Inc